The structure of some essential oils companies makes it harder for federal agencies to restrain false claims.
Scholar claims that regulatory sandboxes such as emergency use authorizations boost innovation, but at a cost.
Contrary to longstanding precedent, individualism reigns supreme in recent legal decisions over COVID-19.
The collaboration between pharmaceutical giants puts antitrust law at risk.
Questions of equity, access, and privacy demand answers before a vaccine passport will work.
Experts examine the legality and efficacy of vaccine mandates.
Medical expert urges states to balance public health concerns with religious autonomy in creating vaccine policies.
FDA’s approval of an Ebola vaccine can serve as a framework for drug development during other epidemics.
Recent outbreaks of vaccine-preventable diseases fuel debate about vaccine policy.
Legal scholar calls for reform of the National Childhood Vaccine Injury Act.
New York City has taken an unprecedented step to control the spread of measles.
States should shift incentives to reduce nonmedical exemptions while respecting the choice not to vaccinate.